Komori
Occurring Fact4875MediciNova,Inc.Pharmaceuticals

Notice of Change in Major Shareholders

The shares held by 3D Investment Partners Private Limited decreased from 5,502,047 shares (11.18%) to 4,862,047 shares (9.88%), and the company ceased to be a major shareholder. The company stated that this matter will have no impact on its financial results.

Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
640000
Shares (decrease in shares held)
Wording
Definitive
How definitive the wording is.

Changes in Major Shareholders

Subject Entity

3D Investment Partners Private Limited (3D Opportunity Master Fund)

Occurrence29 September 2026 (U.S. time)
Same day
Awareness or receipt of notice29 September 2026 (U.S. time), the date on which the shareholder in question filed a Schedule 13D/A with the U.S. Securities and Exchange Commission (SEC)
This disclosure09/30/2026
Cause

The shareholder in question filed a Schedule 13D/A (substantial shareholding report) with the SEC dated 29 September 2026, and its voting rights ratio fell below 10%.

Amount of Impact on Business Performance

There is no impact on financial results. No amount was disclosed.

Impact on Earnings Forecast

This change will have no impact on the company's financial results.

Change in voting rights ownership ratio

Shareholders Covered11.18%→9.88%(-1.30pt)

The voting rights ownership percentage is the proportion of the voting rights exercisable at a shareholders' meeting held by the shareholder.

Voting rights ownership percentage before the change

5,502,047 voting rights (5,502,047 shares), 11.18%, ranked No. 1 among major shareholders. As of 24 April 2026

Voting rights ownership percentage after the change

4,862,047 voting rights (4,862,047 shares), 9.88%, ranked No. 1 among major shareholders. Based on the 49,221,246 issued shares as of 24 April 2026

Related procedures

Court or authority

U.S. Securities and Exchange Commission (SEC)

Outlook

This change will have no impact on the company's financial results.

Event that occurred
ItemDetails
Event nameChanges in Major Shareholders
Date of occurrence29 September 2026 (U.S. time)
Date recognized / date notice received29 September 2026 (U.S. time), the date on which the shareholder in question filed a Schedule 13D/A with the U.S. Securities and Exchange Commission (SEC)
Subject Entity3D Investment Partners Private Limited (3D Opportunity Master Fund)
CauseThe shareholder in question filed a Schedule 13D/A (substantial shareholding report) with the SEC dated 29 September 2026, and its voting rights ratio fell below 10%.
Amount of Impact on Business PerformanceThere is no impact on financial results. No amount was disclosed.
Impact on Earnings ForecastThis change will have no impact on the company's financial results.
Court or authorityU.S. Securities and Exchange Commission (SEC)
Voting rights ownership percentage before the change5,502,047 voting rights (5,502,047 shares), 11.18%, ranked No. 1 among major shareholders. As of 24 April 2026
Voting rights ownership percentage after the change4,862,047 voting rights (4,862,047 shares), 9.88%, ranked No. 1 among major shareholders. Based on the 49,221,246 issued shares as of 24 April 2026
OutlookThis change will have no impact on the company's financial results.
Items this document does not state (14)
Target Locations / ProductsAccounting period in which recognizedType of litigation or proceedingPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityPlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This is because the shareholder in question filed a Schedule 13D/A with the U.S. Securities and Exchange Commission (SEC) dated 29 September 2026, confirming that its voting rights ratio had fallen below 10%. No specific transaction rationale for the decrease in its shareholding was provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Change in Major Shareholders | MediciNova,Inc. (4875) timely disclosure | Komori